IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations

Genes and Immunity

Volumn 9, Issue 3, 2008, Pages 259-263

  Weber, F ^a   Fontaine, B ^b,c,d,i   Cournu Rebeix, I ^b,c,d   Kroner, A ^e   Knop, M ^a   Lutz, S ^a   Muller Sarnowski F ^a   Uhr, M ^a   Bettecken, T ^a   Kohli, M ^a   Ripke, S ^a   Ising, M ^a   Rieckmann, P ^e,i   Brassat, D ^f   Semana, G ^g   Babron, M C ^c,h   Mrejen, S ^b,c,d   Gout, C ^b,c,d   Lyon Caen, O ^b,c,d   Yaouanq, J ^g   Edan, G ^g   Clanet, M ^f   Holsboer, F ^a   Clerget Darpoux, F ^c,h   Muller Myhsok B ^a   more..

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c INSERM   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e UNIVERSITY OF WÜRZBURG   (Germany)

^f UNIVERSITÉ DE TOULOUSE   (France)

^g PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^h UNIVERSITÉ PARIS SACLAY   (France)

ⁱ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR ALPHA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; EUROPE; FEMALE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MULTIPLE SCLEROSIS; PATHOGENESIS; POPULATION GENETICS; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 42549108701     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2008.14     Document Type: Article

References (32)

1. Rosati G. The prevalence of multiple sclerosis in the world: An update. Neurol Sci 2001; 22: 117-139.
2. Sotgiu S, Pugliatti M, Sotgiu A, Sanna A, Rosati G. Does the 'hygiene hypothesis' provide an explanation for the high prevalence of multiple sclerosis in Sardinia? Autoimmunity 2003; 36: 257-260.
3. Dyment DA, Willer CJ, Scott B, Armstrong H, Ligers A, Hillert J et al Genetic susceptibility to MS: A second stage analysis in Canadian MS families. Neurogenetics 2001; 3: 145-151.
4. Sadovnick AD, Ebers GC, Dyment DA, Risch NJ. Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. Lancet 1996; 347: 1728-1730.
5. Lindsey JW. Familial recurrence rates and genetic models of multiple sclerosis. Am J Med Genet A 2005; 135: 53-58.
6. Oksenberg JR, Barcellos LF. Multiple sclerosis genetics: Leaving no stone unturned. Genes Immun 2005; 6: 375-387.
7. Haines JL, Terwedow HA, Burgess K, Pericak-Vance MA, Rimmler JB, Martin ER et al. Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group. Hum Mol Genet 1998; 7: 1229-1234.
8. Hillert J. Multiple sclerosis: Postlinkage genetics. Clin Neurol Neurosurg 2006; 108: 220-222.
9. Lundmark F, Duvefelt K, Iacobaeus E, Kockum I, Wallstrom E, Khademi M et al. Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet 2007; 39: 1108-1113.
10. Gregory SG, Schmidt S, Seth P, Oksenberg JR, Hart J, Prokop A et al Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 2007; 39: 1083-1091.
11. The International Multiple Sclerosis Genetics Consortium. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007; 357: 851-862.
12. Zhang Z, Duvefelt K, Svensson F, Masterman T, Jonasdottir G, Salter H et al. Two genes encoding immune-regulatory molecules (LAG3 and IL7R) confer susceptibility to multiple sclerosis. Genes Immun 2005; 6: 145-152.
13. Ebers GC, Kukay K, Bulman DE, Sadovnick AD, Rice G, Anderson C et al A full genome search in multiple sclerosis. Nat Genet 1996; 13: 472-476.
14. Oturai A, Larsen F, Ryder LP, Madsen HO, Hillert J, Fredrikson S et al. Linkage and association analysis of susceptibility regions on chromosomes 5 and 6 in 106 Scandinavian sibling pair families with multiple sclerosis. Ann Neurol 1999; 46: 612-616.
15. Akesson E, Coraddu F, Marrosu MG, Massacesi L, Hensiek A, Harbo HF et al. Refining the linkage analysis on chromosome 10 in 449 sib-pairs with multiple sclerosis. J Neuroimmunol 2003; 143: 31-38.
16. Matesanz F, Caro-Maldonado A, Fedetz M, Fernandez O, Milne RL, Guerrero M et al. IL2RA/CD25 polymorphisms contribute to multiple sclerosis susceptibility. J Neurol 2007; 254: 682-684.
17. Sawcer S. A new era in the genetic analysis of multiple sclerosis. Curr Opin Neurol 2006; 19: 237-241.
18. Ramagopalan SV, Anderson C, Sadovnick AD, Ebers GC. Genomewide study of multiple sclerosis. N Engl J Med 2007; 357: 2199-2200.
19. Matesanz F, Fernandez O, Alcina A. Genomewide study of multiple sclerosis. N Engl J Med 2007; 357: 2200-2201.
20. Bourgain C, Genin E, Cox N, Clerget-Darpoux F. Are genomewide association studies all that we need to dissect the genetic component of complex human diseases? Eur J Hum Genet 2007; 15: 260-263.
21. Clerget-Darpoux F, Elston RC. Are linkage analysis and the collection of family data dead? Prospects for family studies in the age of genome-wide association. Hum Hered 2007; 64: 91-96.
22. Hafler DA, Slavik JM, Anderson DE, O'Connor KC, De Jager P, Baecher-Allan C. Multiple sclerosis. Immunol Rev 2005; 204: 208-231.
23. Seddon B, Tomlinson P, Zamoyska R. Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat Immunol 2003; 4: 680-686.
24. He YW, Malek TR. Interleukin-7 receptor alpha is essential for the development of gamma delta + T cells, but not natural killer cells. J Exp Med 1996; 184: 289-293.
25. McKay FC, Swain LI, Schibeci SD, Rubio JP, Kilpatrick TJ, Heard RN et al. Haplotypes of the interleukin 7 receptor alpha gene are correlated with altered expression in whole blood cells in multiple sclerosis. Genes Immun 2008; 9: 1-6.
26. Peltonen L. Old suspects found guilty - the first genome profile of multiple sclerosis. N Engl J Med 2007; 357: 927-929.
27. Marrosu MG. Susceptibility to multiple sclerosis: The role of interleukin genes. Lancet Neurol 2007; 6: 846-847.
28. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
29. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.
30. Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J et al The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry 1988; 45 1069-1077.
31. Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, Putz B et al Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 2004; 36: 1319-1325.
32. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003; 25: 115-121.